10 research outputs found
Soil application of volatile compounds emitted by Alternaria alternata enhance yield of pepper plants cultured under greenhouse conditions
Póster presentado en el 2nd World Congress on the use of Biostimulants in Agriculture, celebrado en Florencia del 16 al 19 de noviembre de 2015.Peer Reviewe
Volatile compounds emitted by the plant pathogen Alternaria alternata enhance photosynthesis and promote growth of Arabidopsis by increasing cytokinin production
Póster presentado en el Fresh & glycoprotein symposium, celebrado en Japón en septiembre de 2015.Peer Reviewe
Soil application of volatile compounds emitted by the plant pathogen Alternaria alternata enhance yield of pepper plants cultured under greenhouse conditions
Póster presentado en la International Conference "Plant Biotechnology: Green for Good III", celebrada en Olomouc (República Checa) del 15 al 18 de junio de 2015.Peer Reviewe
Volatile compounds emitted by a wide range of rhizosphere and non-rhizosphere microorganisms promote growth through cytokinin regulated processes
Trabajo presentado en la International Conference "Plant Biotechnology: Green for Good III", celebrada en Olomouc (República Checa) del 15 al 18 de junio de 2015.Peer Reviewe
Volatile compounds emitted by Gram-negative and Gram-positive bacteria and fungi promote growth and starch accumulation through cytokinin regulated processes
Póster presentado en el Fresh & glycoprotein symposium, celebrado en Japón en septiembre de 2015.It is known that volatile emissions from some beneficial rhizobacteria promote growth in plants. Here we show that volatile compounds emitted by the plant pathogen Alternaria alternata promote growth and the accumulation of exceptionally high levels of starch in leaves. Analyses of the volatile exometabolome of this species allowed us to identify several volatile compounds that promote plant growth and drastic metabolic changes. In Arabidopsis,this phenomenon (initially designated as MIVOISAP, for Microbial VOIatiles Induced Starch Accumulation Process) was accompanied by enhanced photosynthetic capacity, likely as a consequence of increased levels of plastidic type of cytokinins (CK). The magnitude of the phenomenon was low in mutants impaired in photoreceptors, CK receptors, plastidial NADP-thioredoxin reductase C(NTRC) and plastidic phosphoglucose isomerase. The overall data showed that (a) production of volatiles promoting plant growth is not restricted to beneficial rhizobacterial species, and (b) Arabidopsis MIVOISAP involves complex photocontrolled processes where in photoreceptors, NTRC-mediated changes in redox status of plastidial target proteins, CK production and signaling play
important roles.Peer Reviewe
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality